These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 7488690)

  • 1. [Effectiveness of serotonergic agonists in the treatment of obese patients].
    Mendoza Espejo R; Díaz Pérez de Madrid J; Buitrago F
    Aten Primaria; 1995 Oct; 16(6):364-6. PubMed ID: 7488690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of hypocaloric diet plus sibutramine treatment on hormonal and metabolic features in overweight and obese women with polycystic ovary syndrome: a randomized, 24-week study.
    Florakis D; Diamanti-Kandarakis E; Katsikis I; Nassis GP; Karkanaki A; Georgopoulos N; Panidis D
    Int J Obes (Lond); 2008 Apr; 32(4):692-9. PubMed ID: 18071341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The treatment of the obese non-insulin-dependent patient with d-fenfluramine].
    Daniele E; Coco MP
    Clin Ter; 1996 Apr; 147(4):199-204. PubMed ID: 8766352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotoninergic drug-induced weight loss in carbohydrate craving obese patients.
    Toornvliet AC; Pijl H; Hopman E; Elte-de Wever BM; Meinders AE
    Int J Obes Relat Metab Disord; 1996 Oct; 20(10):917-20. PubMed ID: 8910095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative trial of different regimens of fenfluramine and phentermine in obesity.
    Steel JM; Munro JF; Duncan LJ
    Practitioner; 1973 Aug; 211(262):232-6. PubMed ID: 4580610
    [No Abstract]   [Full Text] [Related]  

  • 6. Balanced hypocaloric diet versus protein-sparing modified fast in the treatment of obesity: a comparative study.
    Iselin HU; Burckhardt P
    Int J Obes; 1982; 6(2):175-81. PubMed ID: 7095973
    [No Abstract]   [Full Text] [Related]  

  • 7. [Tolerance and acceptability of dexfenfluramine in the long-term treatment of obesity in private practice. ESIM Group].
    Héraïef E
    Rev Med Suisse Romande; 1997 Jan; 117(1):19-24. PubMed ID: 9082531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Judicious use of anorectics].
    Laurent-Jaccard A
    Schweiz Rundsch Med Prax; 1991 Feb; 80(6):116-7. PubMed ID: 2003174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged use of a very low calorie diet (Cambridge diet) in massively obese patients attending an obesity clinic: safety, efficacy and additional benefit from dexfenfluramine.
    Finer N; Finer S; Naoumova RP
    Int J Obes; 1989; 13 Suppl 2():91-3. PubMed ID: 2613434
    [No Abstract]   [Full Text] [Related]  

  • 10. Appraisal of the clinical value of serotoninergic drugs.
    Munro JF; Scott C; Hodge J
    Am J Clin Nutr; 1992 Jan; 55(1 Suppl):189S-192S. PubMed ID: 1728833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Is it possible to obtain a reduction of body weight exclusively via a loss in fat mass? Experience with d-fenfluramine].
    Del Ponte A; D'Orazio N; Di Giacomo G; Tritella T; Bitti G; Martines G
    Recenti Prog Med; 1993 Feb; 84(2):100-5. PubMed ID: 8465086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pharmacologic management of obesity.
    Cerda JJ
    J Fla Med Assoc; 1997 Feb; 84(2):89-92. PubMed ID: 9066231
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of dexfenfluramine on eating behavior and body weight of obese patients: results of a field study of Isomeride in Austrian general practice].
    Geyer G; Haidinger G; Francesconi M; Langmayr N; Prager R; Schoberberger R; Toplak H; von Kalckreuth G; Kunze M
    Acta Med Austriaca; 1995; 22(5):95-101; 104-9. PubMed ID: 8651045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Different therapies in the treatment of obesity in hypertensive patients].
    Monego ET; Peixoto Mdo R; Jardim PC; Sousa AL; Braga VL; Moura MF
    Arq Bras Cardiol; 1996 Jun; 66(6):343-7. PubMed ID: 9035450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Long-term results of treatment of obesity].
    Wechsler JG; Ditschuneit H
    Med Klin; 1980 Jul; 75(15):544-50. PubMed ID: 7001202
    [No Abstract]   [Full Text] [Related]  

  • 16. Predictors of weight loss during treatment with d-fenfluramine.
    Toornvliet AC; Pijl H; Hopman E; Westendorp RG; Meinders AE
    J Intern Med; 1997 May; 241(5):401-6. PubMed ID: 9183308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.
    Pasquali R; Gambineri A; Biscotti D; Vicennati V; Gagliardi L; Colitta D; Fiorini S; Cognigni GE; Filicori M; Morselli-Labate AM
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2767-74. PubMed ID: 10946879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of obese adolescents with sibutramine: a randomized, double-blind, controlled study.
    Godoy-Matos A; Carraro L; Vieira A; Oliveira J; Guedes EP; Mattos L; Rangel C; Moreira RO; Coutinho W; Appolinario JC
    J Clin Endocrinol Metab; 2005 Mar; 90(3):1460-5. PubMed ID: 15613431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapy of obesity].
    Wechsler JG
    Internist (Berl); 1995 Nov; 36(11):1063-9. PubMed ID: 8543442
    [No Abstract]   [Full Text] [Related]  

  • 20. Differences in glycaemic status do not predict weight loss in response to hypocaloric diets in obese patients.
    de Luis DA; Aller R; Izaola O; Gonzalez Sagrado M; Conde R
    Clin Nutr; 2006 Feb; 25(1):117-22. PubMed ID: 16278036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.